Andrew Cooper
Stock Analyst at Raymond James
(2.30)
# 2,570
Out of 4,670 analysts
121
Total ratings
43.75%
Success rate
-3.24%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Upgrades: Strong Buy | $120 | $85.55 | +40.27% | 7 | Nov 8, 2024 | |
| RVTY Revvity | Maintains: Outperform | $144 → $146 | $112.03 | +30.32% | 5 | Nov 5, 2024 | |
| HOLX Hologic | Maintains: Outperform | $93 → $95 | $78.97 | +20.30% | 10 | Nov 5, 2024 | |
| DHR Danaher | Maintains: Outperform | $310 → $300 | $235.84 | +27.20% | 6 | Oct 23, 2024 | |
| EXAS Exact Sciences | Reiterates: Market Perform | n/a | $52.91 | - | 8 | Sep 26, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $650 → $660 | $513.26 | +28.59% | 5 | Jul 25, 2024 | |
| CDNA CareDx | Downgrades: Market Perform | n/a | $23.13 | - | 16 | May 13, 2024 | |
| NTRA Natera | Downgrades: Outperform | $68 → $85 | $167.26 | -49.18% | 5 | Feb 20, 2024 | |
| QDEL QuidelOrtho | Downgrades: Outperform | $100 → $76 | $40.14 | +89.34% | 12 | Feb 14, 2024 | |
| AVTR Avantor | Maintains: Outperform | $23 → $26 | $20.78 | +25.12% | 12 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $27 | $32.65 | -17.30% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $6.55 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $45.16 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.39 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $27 | $15.49 | +74.31% | 3 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $39.59 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $45 | $17.87 | +151.82% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.88 | - | 5 | Sep 22, 2021 |
Haemonetics
Nov 8, 2024
Upgrades: Strong Buy
Price Target: $120
Current: $85.55
Upside: +40.27%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $144 → $146
Current: $112.03
Upside: +30.32%
Hologic
Nov 5, 2024
Maintains: Outperform
Price Target: $93 → $95
Current: $78.97
Upside: +20.30%
Danaher
Oct 23, 2024
Maintains: Outperform
Price Target: $310 → $300
Current: $235.84
Upside: +27.20%
Exact Sciences
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $52.91
Upside: -
Thermo Fisher
Jul 25, 2024
Maintains: Outperform
Price Target: $650 → $660
Current: $513.26
Upside: +28.59%
CareDx
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $23.13
Upside: -
Natera
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $167.26
Upside: -49.18%
QuidelOrtho
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $40.14
Upside: +89.34%
Avantor
Jan 26, 2024
Maintains: Outperform
Price Target: $23 → $26
Current: $20.78
Upside: +25.12%
Nov 13, 2023
Upgrades: Outperform
Price Target: $27
Current: $32.65
Upside: -17.30%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $6.55
Upside: -
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $45.16
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.39
Upside: -
Mar 3, 2023
Maintains: Outperform
Price Target: $25 → $27
Current: $15.49
Upside: +74.31%
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $39.59
Upside: -
Nov 18, 2022
Initiates: Outperform
Price Target: $45
Current: $17.87
Upside: +151.82%
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.88
Upside: -